2021-01-11,MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners
2020-12-29,MediciNova Receives Notice of Allowance forÂ New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS
2020-12-15,MediciNova Added to the NASDAQ Biotechnology Index
2020-11-30,Is MediciNova (MNOV) A Good Stock To Buy Now?
2020-11-25,MediciNova Announces Positive Optical Coherence Tomography Results from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS Published in Multiple Sclerosis Journal
2020-11-24,MediciNova Announces Initiation of Master Virus Seed Stock Production for its Intranasal COVID-19 Vaccine using BC-PIV Vector Technology
2020-11-12,MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience 2020
2020-10-30,MNOV: Intranasal SARS-CoV-2 Vaccine Induces Neutralizing Antibodies in Preclinical Studies
2020-10-26,MediciNova (NASDAQ:MNOV) Is In A Strong Position To Grow Its Business
2020-10-22,"MediciNova, in Collaboration with the University of Sydney and the Australasian Gastro-Intestinal Trials Group, Announces Plans for a Multi-center, Phase 2b Study to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy"
2020-10-21,MediciNova Appoints Carolyn Beaver to its Board of Directors and as Audit Committee Chair
2020-10-13,MediciNova Announces Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model to be Presented at The Liver Meeting Digital Experience 2020
2020-09-24,"Company News for Sep 24, 2020"
2020-09-24,MediciNova Announces Positive Clinical Results Regarding MN-166 (ibudilast) for Prevention of Chemotherapy-induced Peripheral Neuropathy Published in Cancer Chemotherapy and Pharmacology
2020-09-23,MediciNova Stock Spikes on Coronavirus-Vaccine Progress
2020-09-23,"The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma"
2020-09-23,MediciNova Announces that its Intranasal COVID-19 Vaccine Successfully Induced Systemic IgG and Mucosal IgA Neutralizing Antibodies Against SARS-CoV-2 in Mice using BC-PIV Vector Technology
2020-09-11,MediciNova Announces that BioComos Intranasal RS Virus Vaccine Successfully Induced Neutralizing Antibodies against the RS Virus in Mice using BC-PIV Technology
2020-09-02,MNOV: Update on Intranasal SARS-CoV-2 Vaccine
2020-09-01,"The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent"
2020-09-01,MediciNova Announces Development Progress on Intranasal Formulation of SARS-CoV-2 Vaccine for COVID-19
2020-08-06,MediciNova Announces the Presentation of Positive Results from Phase 2 Trial of MN166 (ibudilast) in Alcohol Use Disorder at the American Psychological Association 2020 Annual Convention
2020-08-04,MNOV: Developing SARS-CoV-2 Vaccine Based on Parainfluenza Virus Vector
2020-08-04,MediciNova to Participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference
2020-07-28,"The Daily Biotech Pulse: Spectrum's Positive Dementia Readout, Pfizer, BioNTech Start Late-Stage Coronavirus Trial, resTORbio Receives COVID-19 Funding"
2020-07-27,Here's Why MediciNova Is Soaring Today
2020-07-27,MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan
2020-07-20,MediciNova to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit
2020-07-02,MNOV: FDA Gives OK to Initiate Clinical Trial of MN-166 to Prevent ARDS in COVID-19 Patients
2020-07-01,MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) for Prevention of Acute Respiratory Distress Syndrome in Patients with COVID-19
2020-06-26,"The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts"
2020-06-25,MediciNova Announces Positive Preclinical Results Regarding MN-166 (ibudilast) in Glioblastoma (GBM) Published in Frontiers in Immunology
2020-06-24,"The Daily Biotech Pulse: MediciNova On Track For European Patent Win, Partial Clinical Hold Lifted For Innate Pharma, Tela Bio Details Coronavirus Impact"
2020-06-23,"MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Europe"
2020-06-12,"Hedge Funds Are Cashing Out Of MediciNova, Inc. (MNOV)?"
2020-05-01,MNOV: Multiple Shots on Goal Provide Substantial Potential Upside
2020-04-27,"Have Insiders Been Buying MediciNova, Inc. (NASDAQ:MNOV) Shares This Year?"
2020-04-20,MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
2020-04-14,MNOV: MN-166 Trial in ARDS to Initiate at Yale University
2020-04-08,"The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO"
2020-04-08,MediciNova Announces Plans to Initiate a Clinical Trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)
2020-03-12,MNOV: MN-166 to be Developed as a Treatment for Severe Pneumonia and Acute Respiratory Distress Syndrome
2020-03-09,MediciNova Announces Plans to Develop MN-166 (ibudilast) for Severe Pneumonia and Acute Respiratory Distress Syndrome (ARDS)
2020-02-27,"Should You Be Concerned About MediciNova, Inc.'s (NASDAQ:MNOV) Historical Volatility?"
2020-02-25,MNOV: Multiple Trials of MN-166 Ongoing; Recent Price Move Creates Buying Opportunity
2020-02-17,MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in Japan
2020-01-28,"The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics"
2020-01-27,MediciNova Receives Notice of Intention to Grant for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in Europe
2019-12-04,"MediciNova Announces Additional Analyses from Completed Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 30th International Symposium on ALS/MND in Perth, Australia"
2019-11-18,We're Not Worried About MediciNova's (NASDAQ:MNOV) Cash Burn
2019-11-06,"Here is What Hedge Funds Think About MediciNova, Inc. (MNOV)"
2019-10-30,MNOV: Phase 3 Trial Initiated for MN-166 in ALS
2019-10-28,MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada
2019-10-23,MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of NAFLD and NASH in Japan
2019-10-07,MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Idiopathic Pulmonary Fibrosis in Japan
2019-09-30,MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in China
2019-09-19,"Does Market Volatility Impact MediciNova, Inc.'s (NASDAQ:MNOV) Share Price?"
2019-09-11,MediciNova to Present at the Ladenburg Thalmann 2019 Healthcare Conference in New York
2019-08-29,MediciNova to Attend the Morgan Stanley Global Healthcare Conference in New York
2019-08-14,MNOV: Abstract on MN-166 to be Presented at ALS/MND International Symposium
2019-07-30,MediciNova Announces MN-001 Research Collaboration with the National Cerebral and Cardiovascular Disease Research Center in Japan
2019-07-29,"MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 30th International Symposium on ALS/MND in Perth, Australia"
2019-07-24,MediciNova Appoints Kazuko Matsuda to its Board of Directors
2019-07-18,MNOV: Readying for Phase 3 Trial in Multiple Sclerosis
2019-07-18,"What Type Of Shareholder Owns MediciNova, Inc.'s (NASDAQ:MNOV)?"
2019-07-11,MediciNova Announces Phase 3 Clinical Trial Plan for MN-166 (ibudilast) in Progressive MS
2019-06-12,MediciNova to Present at the JMP Securities Life Sciences Conference
2019-06-05,MediciNova Announces Kick-off Meeting to Officially Launch Phase 3 Trial of MN 166 (ibudilast) in ALS
2019-05-16,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Certain Officers and Directors of MediciNova, Inc."
2019-05-15,MediciNova to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
2019-05-09,MNOV: Plans in Place for Phase 3 Trial in ALS
2019-05-08,"If You Had Bought MediciNova (NASDAQ:MNOV) Stock Five Years Ago, You Could Pocket A 536% Gain Today"
2019-05-07,"MediciNova Participated in the RECEDE Phase 3 Degenerative Cervical Myelopathy Trial Kick-off Meeting, DCM Symposium and the Official Launch of Myelopathy.org in London, United Kingdom"
2019-04-24,"The Daily Biotech Pulse: FDA Greenlights AbbVie's Psoriasis Drug, Novartis Earnings, Patent Notification For MediciNova"
2019-04-23,MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
2019-04-16,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives"
2019-04-15,MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
2019-04-08,MNOV: New Analysis Shows Efficacy of MN-166 in Non-Relapsing SPMS
2019-04-03,"MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in China"
2019-04-01,MediciNova Announces Results of Subgroup Analysis from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS
2019-03-24,"MediciNova Announces Upcoming Presentations Regarding the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive Multiple Sclerosis at the 71st American Academy of Neurology Annual Meeting in Philadelphia, Pennsylvania"
2019-03-05,"MediciNova Announces MN-001 Research Collaboration with The Jikei University School of Medicine in Tokyo, Japan"
2019-02-28,MediciNova Announces the Publication of Results of the Animal Model Study of MN166 (ibudilast) in Glioblastoma in Scientific Reports
2019-02-20,MNOV: Continuing to Plan for Phase 3 Studies in Progressive MS and ALS
2019-02-12,"One Thing To Remember About The MediciNova, Inc. (NASDAQ:MNOV) Share Price"
2019-01-21,MediciNova Receives Notice of Allowance for New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) and other Neurodegenerative Diseases
2019-01-09,"The Daily Biotech Pulse: BioMarin Trims Outlook, MediciNova Enrolls First Patient In Brian Cancer Drug Study"
2019-01-08,MediciNova Announces Initiation of Enrollment in a Clinical Trial of MN-166 (ibudilast) in Glioblastoma
2019-01-07,MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Fibrosis in Japan
2018-12-12,"Do Insiders Own Lots Of Shares In MediciNova, Inc. (NASDAQ:MNOV)?"
2018-12-12,MediciNova to Present at the J.P. Morgan Healthcare Conference in San Francisco
2018-10-31,MNOV: MN-166 to be Studied in Degenerative Cervical Myelopathy
2018-10-05,"The Daily Biotech Pulse: MediciNova Gets Orphan-Drug Status, KemPharm To Offer Shares, Emergent Buys Vaccine Maker"
2018-10-04,MediciNova Announces FDA Grants Orphan Drug Designation to MN-166 (ibudilast) for Glioblastoma
2018-09-28,MNOV: Positive FDA Feedback on ALS Phase 3 Plan
2018-09-25,MediciNova Announces Positive FDA Feedback Regarding Phase 3 Plan for MN-166 (ibudilast) in ALS
2018-09-18,MediciNova to Present at the Ladenburg Thalmann 2018 Healthcare Conference in New York
2018-09-04,MediciNova to Attend the Morgan Stanley Global Healthcare Conference in New York
2018-08-29,MediciNova Announces the Publication of Results of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS in the New England Journal of Medicine
2018-08-20,National Institute on Alcohol Abuse and Alcoholism Awards R01 Research Grant to UCLA for Phase 2b Clinical Trial of MediciNova's MN-166 (ibudilast) in Alcohol Use Disorder
